SPOTLIGHT: Drug companies direct med school research

A large number of teaching hospitals say they're willing to let drug companies take control of new pharmaceutical research, allowing them to draft journal articles and provide research results. But the schools say they're opposed to gag rules that prohibit researchers from publishing negative outcomes. Story

Suggested Articles

In this week's EuroBiotech Report, AstraZeneca plans 2020 lupus filing, Roche's SMA trial hits endpoint and Kiadis cuts staff in R&D pivot.

In our EuroBiotech roundup this week, NEC and Vaximm ink cancer vaccine pact, Compugen posts cancer data and Lunac raises cash.

Biotech venture fund ATAI Life Sciences has partnered with artificial intelligence drug discovery specialist Cyclica to form a new JV.